Xoran Technologies announces that it has completed the Phase 1 milestones of the SBIR project, funded by the NIH and NINDS to demonstrate feasibility of a highly portable and affordable cranial computed tomography perfusion (CT-P) device. “We are proud of this milestone and grateful to NIH and NINDS for their support,” states William van Kampen, Xoran CTO and principal investigator on the project. “Our goal is that in the future this technology will help expedite the front-line evaluation and triage of cerebral stroke victims.”
In 2020 Xoran received this Small Business Innovation Research (SBIR) grant award from the National Institutes of Health (NIH) and the National Institute of Neurological Disorders and Stroke (NINDS). The aims of Phase 1 were both to develop a compact, fast-rotating gantry and to confirm time-resolved contrast imaging feasibility—all to be incorporated in a future device compact enough to be transported by two or less people in a mid-sized civilian or military vehicle, or an ambulance.
in the future, this technology will help expedite the front-line evaluation and triage of cerebral stroke victims.
“What we know about stroke is that ‘time is brain.’ Previously we had few effective therapies for stroke, but in the recent years we have developed extremely robust and successful therapies, as long as we can diagnose and treat the problem in its very early stages. That is why this project is so exciting,” says neurosurgeon William Gormley, MD, MPH, MBA. “Expanding access by setting-up mobile CT-Perfusion scanners that can potentially be deployed in existing ambulances and directly reach affected patients where they are first seen, changes everything. The rapid screening, early detection and diagnosis of cerebral ischemia means we will be able to reverse strokes, save more brain and prevent major morbidity and mortality from this devastating disease.”
Indeed, the combined tens of thousands of ambulances, urgent care centers, and homes for elder care in the United States alone could benefit from an affordable point-of-care CT-P device. Deploying this future device in cities and rural areas means many more individuals suffering from acute stroke can be rapidly evaluated and treated within the beneficial window, thereby reducing disability and improving functional independence and quality of life for affected individuals.